Duloxetine Stress Urinary Incontinence Efficacy and Safety Study

NCT00475397 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence, Stress

Interventions

DRUG: Duloxetine
DRUG: Placebo

Sponsor

Eli Lilly and Company